Literature DB >> 1322186

Correlation of pretransplant viral serology and complications of bone marrow transplantation.

O Ringdén1.   

Abstract

Latent herpes viruses such as herpes simplex virus, cytomegalovirus (CMV), and varicella zoster virus are often reactivated after bone marrow transplantation, giving rise to infections. In contrast, Epstein-Barr virus infections rarely occur. Significant mortality is induced especially by pneumonitis, most often caused by CMV. Immunosuppression and pancytopenia caused by CMV increase the risk of bacterial infections and invasive fungal infections. Herpes viruses may increase the risk of acute and chronic graft-versus-host disease (GVHD). Thus, immunity to several herpes viruses was associated with an increased risk of acute GVHD. Seropositivity for CMV in recipient and donor increased the risk of chronic GVHD. Herpes viruses were also associated with a decreased risk of leukemic relapse. CMV infection, asymptomatic CMV infection, and seropositivity for several herpes viruses were associated with a reduced incidence of relapse in different reports. In spite of this possible antileukemic effect, leukemia-free survival was unaffected by herpes virus immunity in recipients or donors.

Entities:  

Mesh:

Year:  1992        PMID: 1322186     DOI: 10.1007/bf01715369

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  35 in total

1.  Variables predicting deep fungal infections in bone marrow transplant recipients.

Authors:  J Tollemar; O Ringdén; L Boström; B Nilsson; B Sundberg
Journal:  Bone Marrow Transplant       Date:  1989-11       Impact factor: 5.483

2.  Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation.

Authors:  D Guyotat; R Gibert; J Chomel; E Archimbaud; S Bossard; J Maupas; D Fiere; M Aymard
Journal:  J Med Virol       Date:  1987-12       Impact factor: 2.327

3.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

4.  Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection.

Authors:  B Lönnqvist; O Ringdèn; P Ljungman; B Wahren; G Gahrton
Journal:  Br J Haematol       Date:  1986-08       Impact factor: 6.998

5.  The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection. An analysis of risk factors.

Authors:  T Paulin; O Ringdén; B Lönnqvist; B Wahren; B Nilsson
Journal:  Scand J Infect Dis       Date:  1986

6.  Pretransplant herpesvirus serology and acute graft-versus-host disease.

Authors:  L Boström; O Ringdén; B Sundberg; A Linde; J Tollemar; B Nilsson
Journal:  Transplantation       Date:  1988-10       Impact factor: 4.939

7.  The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation.

Authors:  A Heimdahl; T Mattsson; G Dahllöf; B Lönnquist; O Ringdén
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1989-12

8.  Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation.

Authors:  K Atkinson; M M Horowitz; R P Gale; D W van Bekkum; E Gluckman; R A Good; N Jacobsen; H J Kolb; A A Rimm; O Ringdén
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

9.  Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease.

Authors:  B Lönnqvist; O Ringdén; B Wahren; G Gahrton; G Lundgren
Journal:  Transplantation       Date:  1984-11       Impact factor: 4.939

10.  An analysis of factors predisposing to chronic graft-versus-host disease.

Authors:  O Ringdén; T Paulin; B Lönnqvist; B Nilsson
Journal:  Exp Hematol       Date:  1985-11       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.